Cartalax Research Information
Cartilage Support Peptide
Tetrapeptide Bioregulator for Cartilage Research
Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
Contents
What is Cartalax?
Cartalax is a synthetic tetrapeptide bioregulator with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). It is a short-chain peptide with a molecular weight of 417 Da (C₁₅H₂₃N₅O₈).
Cartalax is derived from research into short peptides with tissue-specific regulatory activity on cartilage tissue. It has emerged as a promising molecular tool for investigating chondrocyte biology, extracellular matrix synthesis, and cartilage repair mechanisms in research models.
Mechanism of Action
Cartalax functions through multiple pathways to support cartilage research models:
Chondrocyte Regulation
Modulates chondrocyte proliferation and differentiation pathways
Extracellular Matrix
Stimulates synthesis of collagen type II and proteoglycan components
DNA Interaction
Modulates gene expression through DNA-binding and endonuclease modulation
Research Applications
Cartilage Repair
Investigating peptide-mediated regeneration of articular cartilage tissue
Osteoarthritis Research
Studying disease-modifying potential in OA models
Intervertebral Disc
Researching disc degeneration and repair mechanisms
Gene Expression Studies
Mapping signaling cascades and transcription factor regulation
Clinical Studies
Key Research Findings:
- Clinical research has demonstrated that Cartalax peptides positively influence metabolic processes in chondrocytes
- Enhanced cartilage tissue repair and extracellular matrix regeneration
- Improved functional outcomes in joint models with cartilage degradation
- Research suggests potential for reducing inflammation and promoting cartilage homeostasis
Dosing Guide
Select your vial size and dose to see corresponding volume, clicks, dosing frequency, and doses per vial:
Step 1: Select Vial Size
Step 2: Select Dose
Vial Size
20mg Vial
Selected Dose
2 mg
Doses per Vial
10 doses
Clicks
30 clicks
Volume
0.30 mL
Protocol
Standard
Recommended Schedule
Daily - Research Protocol
Do not change your dose unless advised by a qualified professional.
Reconstitution Instructions
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
20mg vial with 3mL bac water
| Dose | Units on Syringe | Volume (mL) | Protocol |
|---|
Always use a new sterile needle and syringe for each injection.
Safety & Precautions
Do not use if you:
- Are allergic to Cartalax or any components
- Are pregnant or breastfeeding
Warning: If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
References
- Khavinson VKh, Fedoreyeva LI, Vanyushin BF. Short peptides modulate eukaryotic endonuclease activity. Bull Exp Biol Med. 2011
- Cartalax Peptide Research Overview. NovoPro Bioscience
- Cartalax Product Information. MedChemExpress
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: August 2026